Cedars Sinai


 

PD-L1 CPS As a Biomarker for Patient Selection for Immunotherapy in Advanced Esophagogastric Adenocarcinoma

By Cedars Sinai FEATURING Jun Gong
By Cedars Sinai FEATURING Jun Gong
252 views
May 13, 2022
0 Comments
Login to view comments. Click here to Login